Post Image

Vascular disease in scleroderma


2008 Feb;34(1):73-9; vi.
Vascular disease in scleroderma: angiogenesis and vascular repair
Mulligan-Kehoe MJ, Simons M.
Angiogenesis Research Center, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Borwell 530 E, 1 Medical Center Drive, Lebanon, NH 03756, USA.
Abstract
Vascular abnormalities are one of the primary pathologic components of scleroderma. An early vascular indicator is aberrant nail fold capillaries that appear to undergo a switch from a pro- to anti-angiogenic process. Later in the disease process, ineffective and aberrant wound healing becomes apparent with frequent and widespread fibrosis. Pulmonary hypertension, largely due to the loss of pulmonary arterial vasculature, is frequently observed in late stages of the disease. The common theme of all these processes is abnormal regeneration of the vasculature and ongoing vascular losses due to defective maintenance of the vasculature. Although most aspects of vascular injury in scleroderma are poorly understood, certain biologic themes are beginning to emerge that are important in understanding scleroderma-related vascular disease.
PMID: 18329533 [PubMed – indexed for MEDLINE]

Contact Us

Have questions about Stem Cell Therapy?
Fill out the form or contact us below and we’ll be in touch!

Join the Revolution

Learn how to take your practice to the next level. Set up a consultation below

    Cell Surgical Network is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account. From time to time, we would like to contact you about conference details and special pricing, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please check the box below.

    You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy. By clicking submit below, you consent to allow Cell Surgical Network to store and process the personal information submitted above to provide you the content requested.